QUVIVIQ isn't advisable in people with intense hepatic impairment. Lessen the dose in individuals with average hepatic impairment. We urge patients and health care experts to report side effects involving opioids, benzodiazepines, or other medicines for the FDA MedWatch program, applying the information within the “Contact FDA” box at https://benzodiazepinesllistofdru83951.activoblog.com/38156417/bromazolam-pellets-2-5mg-dosage-info